Sonoma Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview

Reuters

08/05

Sonoma Pharmaceuticals Inc <snoa.oq> expected to post a loss of 51 cents a share - Earnings Preview </snoa.oq>

Sonoma Pharmaceuticals Inc SNOA.OQ SNOA.O is expected to show a rise in quarterly revenue when it reports results on August 6 (estimated) for the period ending June 30 2025
The Boulder Colorado-based company is expected to report a 19.4% increase in revenue to $4.05 million from $3.39 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Sonoma Pharmaceuticals Inc is for a loss of 51 cents per share.
The one available analyst rating on the shares is "strong buy".
The average consensus recommendation for the pharmaceuticals peer group is also "Strong Buy".
Wall Street's median 12-month price target for Sonoma Pharmaceuticals Inc is $14.80, about 79.2% above its last closing price of $3.09

This summary was machine generated August 4 at 21:43 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2557372332"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2557372332\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2557372332?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-05 05:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557372332","market":"nz","top_or_hot":-1,"title":"Sonoma Pharmaceuticals Inc  expected to post a loss of 51 cents a share - Earnings Preview","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Sonoma Pharmaceuticals Inc <snoa.oq> expected to post a loss of 51 cents a share - Earnings Preview </snoa.oq></title></head><body><ul><li><p>Sonoma Pharmaceuticals Inc <span>SNOA.OQ</span> <span>SNOA.O</span> is expected to  show a rise in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025</p></li><li><p>The Boulder Colorado-based  company is expected to report a 19.4% increase in revenue to $4.05 million from $3.39 million a year ago, according to the estimate from one analyst, based on LSEG data.</p></li><li><p>LSEG's mean analyst estimate for Sonoma Pharmaceuticals Inc is for a loss of 51 cents per share. </p></li><li><p>The one available analyst rating on the shares is \"strong buy\".  </p></li><li><p>The average consensus recommendation for the pharmaceuticals peer group is also \"Strong Buy\".</p></li><li><p><a href=\"https://laohu8.com/S/WSCO\">Wall Street</a>'s median 12-month price target for Sonoma Pharmaceuticals Inc is $14.80, about 79.2% above its last closing price of $3.09</p></li></ul><p>This summary was machine generated August 4 at 21:43 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonoma Pharmaceuticals Inc  expected to post a loss of 51 cents a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonoma Pharmaceuticals Inc  expected to post a loss of 51 cents a share - Earnings Preview\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-08-05 05:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Sonoma Pharmaceuticals Inc <snoa.oq> expected to post a loss of 51 cents a share - Earnings Preview </snoa.oq></title></head><body><ul><li><p>Sonoma Pharmaceuticals Inc <span>SNOA.OQ</span> <span>SNOA.O</span> is expected to  show a rise in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025</p></li><li><p>The Boulder Colorado-based  company is expected to report a 19.4% increase in revenue to $4.05 million from $3.39 million a year ago, according to the estimate from one analyst, based on LSEG data.</p></li><li><p>LSEG's mean analyst estimate for Sonoma Pharmaceuticals Inc is for a loss of 51 cents per share. </p></li><li><p>The one available analyst rating on the shares is \"strong buy\".  </p></li><li><p>The average consensus recommendation for the pharmaceuticals peer group is also \"Strong Buy\".</p></li><li><p><a href=\"https://laohu8.com/S/WSCO\">Wall Street</a>'s median 12-month price target for Sonoma Pharmaceuticals Inc is $14.80, about 79.2% above its last closing price of $3.09</p></li></ul><p>This summary was machine generated August 4 at 21:43 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNOA","symbol_name":"Sonoma Pharmaceuticals, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL8N3TW2JM:1","article_id":"2557372332","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557372332","pubTimestamp":1754343784,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Sonoma Pharmaceuticals Inc  expected to post a loss of51cents a share - Earnings Preview Sonoma Pharmaceuticals Inc SNOA.OQ SNOA.O is expected to  show a rise in quarterly revenue when it reports  res","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SNOA":"Sonoma Pharmaceuticals, Inc."},"translate_title":"Sonoma Pharmaceuticals Inc预计每股亏损51美分-收益预览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNOA":0.9},"content_text":"Sonoma Pharmaceuticals Inc  expected to post a loss of 51 cents a share - Earnings Preview Sonoma Pharmaceuticals Inc SNOA.OQ SNOA.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025The Boulder Colorado-based  company is expected to report a 19.4% increase in revenue to $4.05 million from $3.39 million a year ago, according to the estimate from one analyst, based on LSEG data.LSEG's mean analyst estimate for Sonoma Pharmaceuticals Inc is for a loss of 51 cents per share. The one available analyst rating on the shares is \"strong buy\".  The average consensus recommendation for the pharmaceuticals peer group is also \"Strong Buy\".Wall Street's median 12-month price target for Sonoma Pharmaceuticals Inc is $14.80, about 79.2% above its last closing price of $3.09This summary was machine generated August 4 at 21:43 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,preview","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}